StrategX Elements Corp. announced a a non-brokered private placement to issue 15,000,000 common shares at an issue price of CAD 0.10 per share for the gross proceeds of CAD 1,500,000 on May 22, 2024. It is proposed that all of the Shares will be purchased by David Haig Associates Inc. which will result in DHA holding 28.5% of the issued shares of the Company, on a non-diluted basis.

As such, DHA will become a new control person. This financing is subject to CSE approval. Pursuant to CSE policies, the creation of a new control person is subject to shareholder approval which may be obtained by way of written consent of shareholders holding 50% + 1 of the issued shares of the Company.

This private placement is expected to close as soon as all approvals have been obtained. The Shares will be subject to a four-month-and-one-day hold period under securities laws in Canada.